Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.16 USD | +2.57% | +10.32% | -44.83% |
Apr. 03 | ModivCare Inc.(NasdaqGS:MODV) dropped from S&P Composite 1500 | CI |
Apr. 03 | ModivCare Inc.(NasdaqGS:MODV) dropped from S&P 600 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The stock, which is currently worth 2024 to 0.5 times its sales, is clearly overvalued in comparison with peers.
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The group shows a rather high level of debt in proportion to its EBITDA.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-44.83% | 335M | C- | ||
-14.15% | 84.68B | B- | ||
+15.10% | 81.12B | C+ | ||
+11.62% | 29.59B | C+ | ||
-9.44% | 16.73B | B | ||
-1.28% | 16.36B | A- | ||
-31.58% | 11.77B | - | - | |
+1.95% | 11.72B | A- | ||
+30.85% | 11.71B | B- | ||
-0.47% | 11.66B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MODV Stock
- Ratings ModivCare Inc.